The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
A panel discussion on non dilutive funding sources for biopharma and medtech startups from government research and industry grants to industry partnerships and venture debt.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.
On the final day of INVEST Precision Medicine, a panel with Caris Health, CVS Health, and Intermountain Healthcare will share assessments of precision medicine's progress and the outlook for this sector. Also, a panel will highlight non dilutive funding opportunities for startups. Register now!
The conference will include conversations with healthcare industry experts from The Steve & Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Vineti, Ori Biotech, CVS Caremark, Caris Life Sciences, HHS, University City Science Center, and more.
Among the areas of interest for employee benefits startups that presented in our Pitch Perfect contest are: electronic patient care records, behavioral health, caregiver support and substance abuse treatment.
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
This week we reveal judges for the Home Health and Employee Benefits tracks at the conference from September 21-25. Register today.
The seed round comes from two funding sources supported by Pennsylvania: Life Sciences Greenhouse of Central Pennsylvania and Ben Franklin Technology Partners/Central and Northeastern Pennsylvania.
Strengthening Partnerships, Expanding Opportunity
Safeguard Scientifics, Ben Franklin Technology Partners of Southeastern Pennsylvania, and the parent company of Independence Blue Cross will invest $50,000 to $1 million in early stage companies.
Help shape the future of healthcare benefits by sharing your insights.
Safeguard Scientifics became a sustaining member of ic@3401, which means it will help to recruit and mentor member companies and bring in new industry collaborators.
Leading Edge Ventures, a $10 million venture investment fund in Delaware is relatively new on the venture scene since its launch last year. Among its targets are early stage and seed stage medical device and IT companies. In a recent interview with Keystone Edge e-newsletter, General Partner Doug Petillo talked about his background as a […]
Directing a child to set up a diagnostic test is one way to illustrate the ease of using a device. That’s the approach Biomeme took for its pitch on crowdfunding website AngeList. Biomeme co-founder Max Perelman’s cute-as-a-button 7-year-old daughter takes on the role of lab assistant. The DreamIt Health Philadelphia graduate developed a test kit […]
For life science entrepreneurs and professionals looking to build a business, search for the next opportunity or simply network, having a LinkedIn page is a necessity. But the passion people devote to looking for a job or investors on LinkedIn can come off as desperation and lead to bad practices like being overly familiar with […]
Nanotechnology and its use in drug development has been a growing area of investment in the U.S. and that growth has been mapped in an interactive infographic by the Project on Emerging Nanotechnologies. The map lists nanotechnology companies and organizations across the country by specialties, such as medicine and health, materials, imaging and microscopy, electronics, […]